Vicarious Surgical (RBOT) Depreciation & Amortization (CF) (2020 - 2025)
Vicarious Surgical (RBOT) reported Depreciation & Amortization (CF) of $352000.0 for Q3 2025, down 30.57% year-over-year from $507000.0 in Q3 2024, and down 14.77% quarter-over-quarter from $413000.0 in Q2 2025.
Vicarious Surgical (RBOT) Depreciation & Amortization (CF) (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $352000.0 in Q3 2025.
- Depreciation & Amortization (CF) for Q3 2025 came in at $352000.0, down 30.57% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.1 million (down 45.85% YoY), and the FY2024 annual result was $2.1 million, up 13.65% from the prior year.
- Depreciation & Amortization (CF) retreated to $352000.0 in Q3 2025 per RBOT's latest filing, from $413000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $542000.0 in Q4 2024 and troughed at $14000.0 in Q4 2021.
- A 5-year average of $336526.3 and a median of $402000.0 in 2022 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2021 and 2022: Depreciation & Amortization (CF) slumped 91.08% in 2021, then soared 2771.43% in 2022.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $14000.0 in 2021, then soared by 2771.43% to $402000.0 in 2022, then jumped by 30.6% to $525000.0 in 2023, then gained by 3.24% to $542000.0 in 2024, then plunged by 35.06% to $352000.0 in 2025.
- Business Quant data shows RBOT's Depreciation & Amortization (CF) at $352000.0 in Q3 2025, $413000.0 in Q2 2025, and $369000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 40.90 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 78.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 67.10 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 123.40 Mn |
| 10 | Vicarious Surgical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 352,000.00 |
| Sep 30, 2025 | 352,000.00 |
| Jun 30, 2025 | 413,000.00 |
| Jun 30, 2025 | 413,000.00 |
| Mar 31, 2025 | 369,000.00 |
| Mar 31, 2025 | 369,000.00 |
| Dec 31, 2024 | 542,000.00 |
| Dec 31, 2024 | 542,000.00 |
| Sep 30, 2024 | 507,000.00 |
| Sep 30, 2024 | 507,000.00 |
| Jun 30, 2024 | 524,000.00 |
| Jun 30, 2024 | 524,000.00 |
| Mar 31, 2024 | 521,000.00 |
| Mar 31, 2024 | 521,000.00 |
| Dec 31, 2023 | 525,000.00 |
| Dec 31, 2023 | 525,000.00 |
| Sep 30, 2023 | 447,000.00 |
| Sep 30, 2023 | 447,000.00 |
| Jun 30, 2023 | 440,000.00 |
| Jun 30, 2023 | 440,000.00 |